Bacille Calmette-Guérin vaccination is associated with lower prevalence of allergic diseases in Indian children

American Journal of Rhinology and Allergy

Volumn 27, Issue 4, 2013, Pages

  Singh, Meenu ^a   Das, Rashmi Ranjan ^b   Kumar, Lata ^a   Kumar, Rajesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPY; BCG VACCINATION; CHILD; CROSS-SECTIONAL STUDY; ECZEMA; FEMALE; HUMAN; INDIAN; MALE; PREVALENCE; PRICK TEST; RHINITIS; RISK ASSESSMENT; SCAR; SCHOOL CHILD;

ADOLESCENT; BCG VACCINE; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERSENSITIVITY; HYPERSENSITIVITY, IMMEDIATE; INDIA; MALE; PREVALENCE; QUESTIONNAIRES; SCHOOLS; STUDENTS; TUBERCULIN TEST; VACCINATION;

EID: 84883317989     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3940     Document Type: Article

References (38)

1. Aggarwal AN, Chaudhry K, Chhabra SK, et al. Prevalence and risk factors for bronchial asthma in Indian adults: a multicentre study. Indian J Chest Dis Allied Sci 48:13-22, 2006.
2. Pal R, Dahal S, and Pal S. Prevalence of bronchial asthma in Indian children. Indian J Community Med 34:310-316, 2009.
3. Alarming rise of Allergy cases in the city. Available online at www. reachouthyderabad.com/business/biznews/batra.htm; accessed November 19, 2012.
4. Pitts SR, Niska RW, Xu J, and Burt CW. National Hospital Ambulatory Medical Care Survey: 2006 Emergency department summary. National health statistics reports, No. 7, Hyattsville, MD: National Center for Health Statistics, 1-35, 2008.
5. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351:1225-1232, 1998.
6. Ait-Khaled N, Pearce N, Anderson HR, et al.; ISAAC Phase Three Study Group. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 64:123-148, 2009.
7. Wierenga EA, Snock M, De Groot C, et al. Evidence for compartmentalization of functional subsets of CD4- lymphocytes in atopic patients. J Immunol 144:465-4656, 1990.
8. Marchant A, Goetghebuer T, Ota MO, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol 163:2249-2255, 1999.
9. Hoft DF, Leonardi C, Milligan T, et al. Clinical reactogenicity of intradermal Bacille Calmette-Guérin vaccination. Clin Infect Dis 28: 785-790, 1999.
10. Kemp EB, Belshe RB, and Hoft DF. Immune responses stimulated by percutaneous and intradermal Bacille Calmette-Guérin. J Infect Dis 174:113-119, 1996.
11. Sarinho E, Schor D, Veloso M, and Lima M. BCG scar diameter and asthma: A case control study. J Allergy Clin Immunol 106:1199-1200, 2000.
12. Marks GB, Ng K, Zhou J, et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: An historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol 111:541-549, 2003.
13. Queiroz Rde M, Sarinho SW, Sarinho ES, and Ximenes RA. Relationship between BCG scar size and asthma in children? Indian Pediatr 41:916-921, 2004.
14. Shirakawa T, Enomoto T, Shimazu S, and Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 275:77-79, 1997.
15. Anderson HR, Poloniecki JD, Strachan DP, et al.; ISAAC Phase I Study Group. Immunization and symptoms of atopic disease in children: Results from the International Study of Asthma and Allergies in Childhood. Am J Public Health 91:1126-1129, 2001.
16. Martignon G, Oryszczyn M-P, and Annesi-Maesano I. Does childhood immunization against infectious diseases protect from the development of atopic disease? Pediatr Allergy Immunol 16:192-200, 2005.
17. Strannegard IL, Larsson LO, Wennergren G, and Strannegard O. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 53:249-254, 1998.
18. Alm JS, Lilja G, Pershagen G, and Scheynius A. Early BCG vaccination and development of atopy. Lancet 350:400-403, 1997.
19. Yilmaz M, Bingol G, Altintas D, and Kendirli SG. Correlation between atopic diseases and tuberculin responses. Allergy 55:664-667, 2000.
20. Omenaas E, Jentoft HF, Vollmer WM, et al. Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax 55:454-458, 2000.
21. Wong GW, Hui DS, Tam CM, et al. Asthma, atopy and tuberculin responses in Chinese school children in Hong Kong. Thorax 56:770-773, 2001.
22. Mohrenschlager M, Haberl VM, Kramer U, et al. Early BCG and pertussis vaccination and atopic diseases in 5-to 7-year-old preschool children from Augsburg, Germany: Results from the MIRIAM study. Pediatr Allergy Immunol 18:5-9, 2007.
23. Arnoldussen DL, Linehan M, and Sheikh A. BCG vaccination and allergy: A systematic review and meta-analysis. J Allergy Clin Immunol 127:246-253, 2011.
24. Gupta D, Aggarwal AN, Kumar R, and Jindal SK. Prevalence of bronchial asthma and association with environmental tobacco smoke exposure in adolescent school children in Chandigarh, north India. J Asthma 38:501-507, 2001.
25. Kuppuswamy B. Manual of socioeconomic status scale (urban). Manasayan, Delhi, 1976.
26. Singh M, Agarwal A, and Chatterjee B. Food allergen in children with asthma: Correlation of clinical features, SPT and serological tests. J Allergy Clin Immunol 123:S191, 2009.
27. Weinmayr G, Weiland SK, Björkstén B, et al.; ISAAC Phase II Study Group. Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med 176: 565-574, 2007.
28. Lai CK, Beasley R, Crane J, et al. Global variation in the prevalence and severity of asthma symptoms: Phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 64: 476-483, 2009.
29. Spergel JM. From atopic dermatitis to asthma: The atopic march. Ann Allergy Asthma Immunol 105:99-106, 2010.
30. Strachan DP. Hay fever, hygiene, and household size. BMJ 299:1259-1260, 1989.
31. Barlan IB, Bahceciler N, Akdis M, and Akdis CA. Role of bacillus Calmette-Guérin as an immunomodulator for the prevention and treatment of allergy and asthma. Curr Opin Allergy Clin Immunol 5:552-557, 2005.
32. Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet 347:1792-1796, 1996.
33. da Cunha SS, Cruz AA, Dourado I, et al. Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG. Allergy 59:857-862, 2004.
34. Arantes GR. The predictive value of the standard tuberculin test in BCG vaccinated children. Rev Saude Publica 26:264-268, 1992.
35. Sarinho ESC, Aguiar ASF, and Silva AMR. Tuberculin sensibility and diameter of scar after vaccination with BCG. Arq Bras Med 67:253-256, 1993.
36. Channabasavaiah R, Mohan M, Suryanarayana HV, et al. Waning of BCG scar and its implications. Indian J Tuberc 40:137, 1993.
37. Mundada V, and Brown N. Evolution of BCG scar and its relation to atopic diseases/asthma and the nutritional status of the child. Arch Dis Child 94:247-248, 2009.
38. Alyasin S, Katibeh K, and Asadi S. The relationship between tuberculin response, BCG vaccine scar and asthma. Iran J Allergy Asthma Immunol 8:205-210, 2009.